757 results on '"Johnson DH"'
Search Results
2. Buses and the Economy II
3. DfT 2006-2008 M6 Toll Road Study: Report on the M6 Toll Road Study Freight SP surveys
4. Competition and the Provision of Rail Passenger Services: A simulation exercise
5. Low-dose computed tomography screening: experiences from the randomized population-based Nelson screening trial
6. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
7. Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer
8. Charging for Scarce Rail Capacity in Britain: A Case Study
9. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 2
10. A New Quantitative Assay for Urinary Leukotriene E4(LTE4) Utilizing Ultra Pressure Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry (UPLC-MS/MS).
11. Scanning Electron Microscopy in Failure Analysis and Aircraft Mishap Investigation
12. Severity of optic nerve damage in eyes with POAG is correlated with changes in the trabecular meshwork.
13. Identifying barriers associated with enrollment of patients with lung cancer into clinical trials.
14. Bevacizumab maintenance in patients with advanced non-small-cell lung cancer, clinical patterns, and outcomes in the eastern cooperative oncology group 4599 study: results of an exploratory analysis.
15. Prognostic models to predict survival in non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin with or without bevacizumab.
16. Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancer.
17. Sex differences in outcome with bevacizumab therapy: analysis of patients with advanced-stage non-small cell lung cancer treated with or without bevacizumab in combination with paclitaxel and carboplatin in the Eastern Cooperative Oncology Group Trial 4599.
18. Book reviews. 'Understanding Addiction as Self Medication: Finding Hope Behind the Pain'.
19. Retrospective evaluation of the clinical and radiographic risk factors associated with severe pulmonary hemorrhage in first-line advanced, unresectable non-small-cell lung cancer treated with Carboplatin and Paclitaxel plus bevacizumab.
20. Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10.
21. Phase I study of adenovirus p53 administered by bronchoalveolar lavage in patients with bronchioloalveolar cell lung carcinoma: ECOG 6597.
22. Evarts A. Graham and the first pneumonectomy for lung cancer.
23. Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
24. Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599.
25. Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer.
26. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10.
27. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels.
28. Combined modality therapy in non-small cell lung cancer.
29. Lazaroids -- not nitric oxide synthetase inhibitors -- improve hemodynamics after thermal injury in anesthetized guinea pigs.
30. Does gefitinib shorten lung cancer survival? Chaos redux.
31. Novel strategies for the treatment of lung cancer: modulation of eicosanoids.
32. Book. A trip down memory lane.
33. Temporal Bone Radiography: A saeening Survey Approach
34. Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on posttherapy fertility in male patients with lymphoma: preliminary observations
35. Combined-modality therapy for unresectable, stage III non-small-cell lung cancer--caveat emptor or caveat venditor?
36. The Brown and Williamson documents. Where do we go from here?
37. Radiographic diagnosis of meningioma
38. Limited value of CT brain scans in the staging of small cell lung cancer
39. Present, future orthopedic care models in Canada focus on increasing efficiency.
40. Bob Jackson--a tribute.
41. Dr. David Johnson Comments on 'Simone's OncOpinion' on the Rise and fall of trust in the medical profession.
42. Keynote comment: Cancer drug pricing in the USA.
43. A positive outlook can overcome orthopedic stress.
44. Hot flashes and related outcomes in breast cancer survivors and matched comparison women.
45. Quantitative Evaluation of a Standard for Immunogold Labeling of Collagen Type IV
46. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer [corrected] [published erratum appears in N ENGL J MED 2007;356(3):318].
47. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.
48. Bevacizumab for non-small-cell lung cancer.
49. Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis†
50. Chemotherapy for lung cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.